Projets de recherche récents
2013/14-2015/16 • $88,556 • Scholarship/Fellowship,Other
Acute myeloid leukemia (AML) is diagnosed annually in ~1,200 patients in Canada. Treatment for this disease has not changed significantly over the last 30 years and the overall survival of AML patients remains close to 20%. Unfortunately, most AML patients relapse within 3 years of diagnosis and...
Applications connexes: WO2018IB58593